Biome Australia Ltd -Positive Results on Clinical Development of BMB18

● Biome has received positive results of core functional characterisation
studies of its strain BMB18
● The strain demonstrated an ability to effectively modulate immune
responses and inflammation, reduce oxidative stress, and maintain
intestinal barrier integrity.
● This report will be used to help inform future clinical research
opportunities and potential health applications and targets for this strain.